Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Histogen Inc
HSTOQ
Healthcare
Biotechnology
Histogen Inc. is a clinical-stage therapeutics company. The Company is focused on developing clinical and preclinical small molecule pan-caspase and caspase selective inhibitors that protect the body’s natural process to restore immune function. Its product candidates include emricasan, CTS-2090 and CTS-2096. It develops emricasan for acute bacterial skin and skin structure infections (ABSSSI...
) as well evaluating its use for other infectious diseases. Its pipeline also includes novel preclinical product candidates including CTS-2090 and CTS-2096, which are selective small molecule inhibitors of caspase-1 designed for the treatment of certain inflammatory diseases. Emricasan is an orally available pan-caspase inhibitor designed to reduce the activities of human caspases, which are enzymes that mediate inflammation and apoptosis. CTS-2090 and CTS-2096 are selective caspase-1 inhibitors targeting inflammasome activation and to treat a variety of inflammation mediated diseases.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (GREY:HSTOQ)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
Next
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Apr 03, 2023 4:05pm
New Press Release - Histogen Announces Exclusive Intellectual Property License Agreement with Johns Hopkins University
Licensed Patents Expected to Provide Freedom to Operate and Exclusivity for EmricasanPipeline Focus on Pan-Caspase and Caspase Selective Inhibitors for Infectious and Inflammatory DiseasesSAN DIEGO, April 03, 2023 (GLOBE NEWSWIRE) -- Histogen Inc. (HSTO), a clinical-stage therapeutics company...
read article.
(72)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Mar 17, 2023 3:52pm
HSTO ..... Thanks for the dough Joe
Cheers to scalping Money for nothing !
Level Up Your Trading with BMO InvestorLine’s Enhanced Features
posted Nov 23, 2024 9:00am by
Bank of Montreal
-
|
Features like Multi-Leg Orders, Options Screener, and Strategy Builder will be particularly exciting for traders. They have been designed to be intuitive and user-friendly, regardless of your experience level. Whether you’re a seasoned pro or just starting out, you’ll find these tools easy to navigate and adapt to your investing style. ...read more
(72)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Mar 17, 2023 3:41pm
HSTO ....in some here at sub $1.29
C what happens
(72)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Mar 17, 2023 3:02pm
HSTO ..... U have to ask yourself....
How on earth does this trade 10 x's it's shares o/s and only be up 45 f'king cents I smell a rat !!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
(72)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Mar 17, 2023 2:47pm
HSTO..... I call this "No Mans Land"
I'm fairly certain of the direction....keeping that to myself for this moment.... $1.31 Cheers !
(72)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Mar 17, 2023 2:36pm
HSTO ..... just remember that this still isn't Strike 3 ; )
The last bastion of support hasn't been breached yet Might still have legs
(72)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Mar 17, 2023 2:33pm
HSTO...... Lol.... I rest my case
U know now !
(72)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Mar 17, 2023 2:25pm
HSTO.... Well Strike 3 hasn't happened ; )
Iy's been all "sideways action" since my post I have support at $1.33 & resisitance at $1.47 Sideways action can be interesting... quite often u will get a breakout one way or the
...more
(72)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Mar 17, 2023 12:02pm
HSTO..... not looking good with declining vols
Strike 3 fast approaching....with support at $1.27....then $1.20....with the last bastion of support at $1.05 Watch for rallies off my support targets.....vols are still there Me no position
...more
(72)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Mar 17, 2023 11:41am
HSTO ..... Strike 2
No position
(72)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Mar 17, 2023 11:08am
HSTO...... N.H.O.D
shouldn't have sold......but one has to be cautious
(72)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Mar 17, 2023 10:51am
HSTO ..... vols are declining
They are still good but 50% lower than the up volime on the 5 min chart
(72)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Mar 17, 2023 10:45am
HSTO ..... I'm done
Stopped out as planned
(72)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Mar 17, 2023 10:42am
HSTO.....my stop is at $1.43
Thx for the dough !
(72)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Mar 17, 2023 10:38am
HSTO ..... Thru RBL....careful here
Keep in mind that it's been doing this all morning Stops save Portfolios
Prev
1
2
3
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >